Clinical Trial Detail

NCT ID NCT01700400
Title Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors "Cancer Research and Biostatistics Clinical Trials Consortium|University of Arizona|Providence Cancer Center, Earle A. C
Indications

non-small cell lung carcinoma

Therapies

Carboplatin

Everolimus

Bevacizumab

Pemetrexed

Age Groups: adult senior

No variant requirements are available.